Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders

Neurodegenerative diseases are a heterogeneous group of disorders whose incidence is likely to duplicate in the next 30 years along with the progressive aging of the western population. Non-cell-specific therapeutics or therapeutics designed to tackle aberrant pathways within neurons failed to slow...

Full description

Bibliographic Details
Main Authors: Chiara F. Valori, Agostino Possenti, Liliana Brambilla, Daniela Rossi
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/8/2019
_version_ 1797524348309864448
author Chiara F. Valori
Agostino Possenti
Liliana Brambilla
Daniela Rossi
author_facet Chiara F. Valori
Agostino Possenti
Liliana Brambilla
Daniela Rossi
author_sort Chiara F. Valori
collection DOAJ
description Neurodegenerative diseases are a heterogeneous group of disorders whose incidence is likely to duplicate in the next 30 years along with the progressive aging of the western population. Non-cell-specific therapeutics or therapeutics designed to tackle aberrant pathways within neurons failed to slow down or halt neurodegeneration. Yet, in the last few years, our knowledge of the importance of glial cells to maintain the central nervous system homeostasis in health conditions has increased exponentially, along with our awareness of their fundamental and multifaced role in pathological conditions. Among glial cells, astrocytes emerge as promising therapeutic targets in various neurodegenerative disorders. In this review, we present the latest evidence showing the astonishing level of specialization that astrocytes display to fulfill the demands of their neuronal partners as well as their plasticity upon injury. Then, we discuss the controversies that fuel the current debate on these cells. We tackle evidence of a potential beneficial effect of cell therapy, achieved by transplanting astrocytes or their precursors. Afterwards, we introduce the different strategies proposed to modulate astrocyte functions in neurodegeneration, ranging from lifestyle changes to environmental cues. Finally, we discuss the challenges and the recent advancements to develop astrocyte-specific delivery systems.
first_indexed 2024-03-10T08:56:05Z
format Article
id doaj.art-fb20540b10c44b95961b071959d2a7df
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T08:56:05Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-fb20540b10c44b95961b071959d2a7df2023-11-22T07:10:35ZengMDPI AGCells2073-44092021-08-01108201910.3390/cells10082019Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative DisordersChiara F. Valori0Agostino Possenti1Liliana Brambilla2Daniela Rossi3Molecular Neuropathology of Neurodegenerative Diseases, German Centre for Neurodegenerative Diseases (DZNE), 72076 Tübingen, GermanyLaboratory for Research on Neurodegenerative Disorders, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, ItalyLaboratory for Research on Neurodegenerative Disorders, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, ItalyLaboratory for Research on Neurodegenerative Disorders, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, ItalyNeurodegenerative diseases are a heterogeneous group of disorders whose incidence is likely to duplicate in the next 30 years along with the progressive aging of the western population. Non-cell-specific therapeutics or therapeutics designed to tackle aberrant pathways within neurons failed to slow down or halt neurodegeneration. Yet, in the last few years, our knowledge of the importance of glial cells to maintain the central nervous system homeostasis in health conditions has increased exponentially, along with our awareness of their fundamental and multifaced role in pathological conditions. Among glial cells, astrocytes emerge as promising therapeutic targets in various neurodegenerative disorders. In this review, we present the latest evidence showing the astonishing level of specialization that astrocytes display to fulfill the demands of their neuronal partners as well as their plasticity upon injury. Then, we discuss the controversies that fuel the current debate on these cells. We tackle evidence of a potential beneficial effect of cell therapy, achieved by transplanting astrocytes or their precursors. Afterwards, we introduce the different strategies proposed to modulate astrocyte functions in neurodegeneration, ranging from lifestyle changes to environmental cues. Finally, we discuss the challenges and the recent advancements to develop astrocyte-specific delivery systems.https://www.mdpi.com/2073-4409/10/8/2019neurodegenerative diseasesastrocytesneuroinflammationrehabilitationtargeted therapy
spellingShingle Chiara F. Valori
Agostino Possenti
Liliana Brambilla
Daniela Rossi
Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
Cells
neurodegenerative diseases
astrocytes
neuroinflammation
rehabilitation
targeted therapy
title Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
title_full Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
title_fullStr Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
title_full_unstemmed Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
title_short Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
title_sort challenges and opportunities of targeting astrocytes to halt neurodegenerative disorders
topic neurodegenerative diseases
astrocytes
neuroinflammation
rehabilitation
targeted therapy
url https://www.mdpi.com/2073-4409/10/8/2019
work_keys_str_mv AT chiarafvalori challengesandopportunitiesoftargetingastrocytestohaltneurodegenerativedisorders
AT agostinopossenti challengesandopportunitiesoftargetingastrocytestohaltneurodegenerativedisorders
AT lilianabrambilla challengesandopportunitiesoftargetingastrocytestohaltneurodegenerativedisorders
AT danielarossi challengesandopportunitiesoftargetingastrocytestohaltneurodegenerativedisorders